The forecast revenue for ST1 around $155m currently exceeds its market cap, and this stock has been well oversold. For a profitable company, the SP has dropped to a level that is ridiculously cheap, but one suspects it won't stay there for very long. I'm reasonably confident that the Q2 revenues due out in the next couple of weeks will be fully on track with forecasts, and the SP will snap back.
All IMHO, DYOR
- Forums
- ASX - By Stock
- Ann: Change of Director's Interest Notice
The forecast revenue for ST1 around $155m currently exceeds its...
Featured News
Add ST1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.6¢ |
Change
-0.001(1.75%) |
Mkt cap ! $105.8M |
Open | High | Low | Value | Volume |
5.8¢ | 5.8¢ | 5.6¢ | $18.48K | 330.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28361 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 940491 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28361 | 0.055 |
1 | 333809 | 0.054 |
3 | 650000 | 0.052 |
3 | 82010 | 0.050 |
1 | 80000 | 0.049 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 940491 | 4 |
0.059 | 14000 | 1 |
0.060 | 2000 | 1 |
0.062 | 16129 | 1 |
0.063 | 508978 | 2 |
Last trade - 10.40am 15/11/2024 (20 minute delay) ? |
Featured News
ST1 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online